Mesoblast (MESO) Current Deferred Revenue (2015 - 2020)

Mesoblast has reported Current Deferred Revenue for 9 years, with the latest figure at $2.5 million in Q4 2025.

• Quarterly Current Deferred Revenue changed 0.0% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $2.5 million, changed 0.0% from the prior year.
• Current Deferred Revenue was little changed at $2.5 million in Q4 2025 per MESO's latest filing, from $2.5 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $2.5 million in Q1 2021 and troughed at $2.5 million in Q1 2021.
• A 5-year average of $2.5 million and a median of $2.5 million in 2021 frame the typical range for Current Deferred Revenue.
• The widest YoY moves for Current Deferred Revenue: up 0.0% in 2021, down 0.0% in 2021.
• Over 5 years, Current Deferred Revenue stood at $2.5 million in 2021, then changed by 0.0% to $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then changed by 0.0% to $2.5 million in 2024, then changed by 0.0% to $2.5 million in 2025.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $2.5 million, $2.5 million, and $2.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.